How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Biomedical Sciences industry affect EB-2 NIW petition outcomes?

The Biomedical Sciences sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW)

Postdoctoral Researcher

Biomedical Sciences · China · 2025-01-24

Processing Time

90 days

Decision Date

2025-01-24

Location

Ohio

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The petitioner's research on immunotherapies for cancer and autoimmune diseases was found to have significant potential to improve public health and reduce medical costs.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record in highly ranked journals, and 145 citations demonstrate his capability to lead this research.

3 Waiver Benefit Met

The urgency of improving cancer treatments and the petitioner's past success make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biomedical and veterinary sciences and a strong record of 9 peer-reviewed journal articles and 5 abstracts. His work earned 145 citations and he completed 18 peer reviews for academic journals. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of his immunotherapy research and his history of funding from the Alliance for Lupus Research.

Evidence

Evidence Types

Peer Reviewed Publications

Citations

Reference Letters Dependent

Grants

Judging Experience

Original Contributions

Similar Cases

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved

New York 64 days 2025-02-24

The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.

View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved

California 354 days 2025-04-03

The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.

View Case

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved

323 days 2025-06-16

The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.

View Case

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved

Tennessee 646 days 2025-11-14

The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.

View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-24.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 90 days

Criteria Met 3 / 3

Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813

Success Rate 53.7%

Sustained 2,046

Dismissed 1,671

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist

Postdoctoral Researcher

Proposed Endeavor

Framework Evaluation

Why This Petition Was Approved

Evidence

Similar Cases

Research Scientist

Research Scientist

Business Manager

Postdoctoral Researcher

Frequently Asked Questions

Browse More Cases

At a Glance

EB-2 (NIW) Case Data

Related Pages

Get Case Insights